1832 Asset Management L.P. Abiomed Inc Transaction History

1832 Asset Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $4.46 Million - $6.26 Million	-28,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $4.92 Million - $7.82 Million	28,000 New	28,000 $4.93 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $92.1 Million - $121 Million	-333,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $39.9 Million - $63.1 Million	141,927 Added 74.16%	333,300 $106 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $3.7 Million - $4.69 Million	-10,427 Reduced 5.17%	191,373 $84.3 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $47.5 Million - $76.3 Million	-170,900 Reduced 45.85%	201,800 $80.5 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $423,478 - $650,870	-2,200 Reduced 0.59%	372,700 $106 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $3.56 Million - $4.21 Million	21,100 Added 5.96%	374,900 $68.4 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $51.4 Million - $59.7 Million	353,800	353,800 $56.7 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.